The inhibition of the acetylcholinesterase (AChE) enzyme, which catalyzes the breakdown of ACh, may be one of the most realistic approaches to the symptomatic treatment of AD [83,85,86]. The gene discussed is ACHE; the disease is Alzheimer disease.